OMEZA Holdings announces new partnership with Spartan Medical
The new exclusive partnership opens access to OMEZA's OCM™ (OMEZA Complete Matrix) for our active Military, Veterans, and beneficiaries of Indian Health Services. OCM™ provides multimodal benefits for advanced acute and chronic wounds in various settings, around the world, where these beneficiaries are served. OCM™ is an FDA-cleared drug-device wound matrix derived from marine lipids and cold-water fish peptides. Applied in various settings, OCM™ reduces inflammation, disrupts bacterial biofilm, and supports tissue regeneration, offering a highly effective and cost-efficient alternative to traditional skin grafts. Spartan Medical can be contacted for information and ordering processes for OCM™. OMEZA proudly manufactures in the USA. VA/DOD customers please contact Spartan Customer Service team at [email protected] or call 888-240-8091.
SARASOTA, Fla., Sept. 28, 2026 /PRNewswire-PRWeb/ --

"Transforming Wound Care Through Marine Science"
- Omeza® Holdings, Inc. is a U.S.-based ocean biotechnology company developing and commercializing marine-derived peptides and lipid products, with an FDA-cleared product, OCM™, already on the market and ongoing clinical programs to expand reimbursement and indications. Omeza products are formulated and manufactured in Sarasota, Florida. (USA)
About Spartan Medical Inc.
- Spartan Medical is a veteran-owned-and-operated government contractor for the U.S. Department of Veterans Affairs, the U.S. Department of Defense, and other local, state, and federal agencies. All senior executives have held leadership positions in both the public and private sector and employ the core strengths of solving complex problems through creative thinking, innovative solutions, and highly skilled flexible teams.
- "Spartan Medical has built its wound care portfolio 'brick by brick' to bring the most advanced medical technologies to our Veterans and Service Members. Through all stages of chronic or acute wound healing processes, we are in the fight with a second-to-none armamentarium of wound care solutions. OMEZA's OCM™ is an outstanding addition, ready now, to deploy across the federal marketplace." Vince Profitt Founder and President, Spartan Medical.
Media Contact
Bernadette Cupit, OMEZA LLC, 1 9083344554, [email protected], https://omeza.com/

View original content to download multimedia:https://www.prweb.com/releases/omeza-holdings-announces-new-partnership-with-spartan-medical-302880340.html
SOURCE OMEZA LLC
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PSignite's CPGvision Platform Earned Six Best-in-Class Category Distinctions in the 2026 POI Enterprise Planning and Retail Execution Vendor Panorama
- Florida Tutoring Advantage selects Lumen, by Littera, to support statewide implementation
- Black Unicorn Digital Solutions Crosses 450 D2C Brands Scaled, Moves to Founder-Led Model as Ad Platforms Automate Media Buying
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share